Substack · Lorenzo2cents · Lorenzo Bastianelli
Lemonade: the most profitable insurer
$LMND Q2 2026 Earnings Update
Since publication −15.0% α −16.0 pp vs S&P 500 · USD
US · 5 entries · 3 publications
Lemonade
No entry states a stance.
Free during launch: log in or sign up with your email to see it.
Sign up freeSubstack · Lorenzo2cents · Lorenzo Bastianelli
$LMND Q2 2026 Earnings Update
Since publication −15.0% α −16.0 pp vs S&P 500 · USD
Substack · Lorenzo2cents · Lorenzo Bastianelli
$LMND Q1 2026 Earnings Update
Since publication −18.1% α −24.7 pp vs S&P 500 · USD
Substack · Benz
El acceso exclusivo a la telemetría del software FSD construye un foso defensivo imbatible basado en la asimetría de información y la precisión algorítmica
Since publication LMND −30.0% α −45.9 pp vs S&P 500 · USD
Substack · Pierce Capital Research · Steve Wagner
Taking a Look at Lemonade (LMND) & Relay Therapeutics (RLAY) Earnings Results.
Since publication LMND −13.9% α −34.4 pp vs S&P 500 · USD
Substack · Pierce Capital Research · Steve Wagner
Taking a Look at AST SpaceMobile (ASTS), Lemonade (LMND), & Our Free Trial.
Since publication LMND +6.1% α −16.1 pp vs S&P 500 · USD
Prices as of the Oct 27, 2026 close. Past performance does not guarantee future results. Price-only, excluding dividends, in local currency. Data may be delayed or inaccurate. Not investment advice. How it is calculated.